Biotechnology Market Reports

Kalorama Information is your trusted source for market research on the biotechnology industry. Reports provide key industry trends, projections, and in-depth analysis for the markets you compete in. Our analysts work closely with biotech industry leaders to provide keen insights into consumer and institutional trends.

<< back 1 2 3 4 next >>

Title	Published	Price
Transgenic Animals and Plants in Pharmaceutical Research and Manufacturing With the mapping of the human genome and the concomitant explosion of proteomics, a steady stream of biopharmaceuticals have been launched—recombinant therapeutic proteins, monoclonal antibody-based products used for therapeutic or in vivo diagnostic purposes, and nucleic acid-based products. As the rate of regulatory approval for biopharmaceuticals increases, the  |  more... Buy by the section | Search inside this report	Jan 1, 2006	$2,995.00
Outsourcing in Drug Discovery, 2nd Edition In the Spring of 2003, Kalorama published its first report on Outsourcing in Drug Discovery. Since then, so much has changed, the use of the term "2nd Edition" hardly seems appropriate. This new study involved completely re-examining the market from the ground up. This new report is designed  |  more... Buy by the section | Search inside this report	Jan 1, 2006	$2,995.00
The Future of Biotechnology Instrumentation The field of biotechnology instrumentation has been an expanding one ever since the emergence of the Human Genome Project 20 years ago. Although the filed certainly existed prior to that point in time, it was the Human Genome Project with its major access to key universities, national laboratories, and  |  more... Buy by the section | Search inside this report	Jan 1, 2006	$2,995.00
Advanced Drug Delivery: Technologies, Applications, and Markets, 2nd Ed. This completely updated 2nd edition to Kalorama’s popular 2003 study focuses on the market applications of current and advanced drug delivery technology to the development of new and modified pharmaceutical products in the United States. Taking a strategic view of the various therapeutic areas on which drug delivery is  |  more... Buy by the section | Search inside this report	Nov 15, 2005	$3,500.00
Glycosylated Protein Therapeutics: A Market Briefing One of the keys to understanding many complex biological interactions, is the role played by specific carbohydrates. This is glycobiology. While many glycobiology-related products commercialized to date are detection and analysis kits for analyzing glycoproteins and the extent of glycosylation, a newer body of research is harnessing glycobiology to develop  |  more... Search inside this report	Sep 1, 2005	$795.00
Wound Care Markets, 2nd Edition, Vol III: Surgical and Trauma Wounds Surgical and trauma wounds are, by far, the most common types of wounds addressed in the wound care area, but it is by no means the easiest to compete in. There are millions of surgical procedures performed annually worldwide; in the United States alone, there are over 100,000 surgeries performed  |  more... Buy by the section | Search inside this report	Sep 1, 2005	$2,995.00
Wound Care Markets, 2nd Edition, Vol II: Burns Approximately 27 million burn cases requiring professional treatment occur worldwide each year, and of these 7 million will require hospitalization and more than a million will die as a direct result of their burns. Burn injuries are a particularly difficult and painful area of medicine requiring multi-pronged approach to address  |  more... Buy by the section | Search inside this report	Aug 1, 2005	$2,995.00
Wound Care Markets, 2nd Edition, Vol I: Skin Ulcers The aging of the population and continued advances in biotechnology drive the skin ulcer portion of the wound care industry, estimated at $3.3 billion globally. A lack of effective treatment options has heretofore added to the increased costs of skin ulcer treatment and has contributed to the growing frustration in  |  more... Buy by the section | Search inside this report	Jul 1, 2005	$2,995.00
Synthetic Blood Substitutes and Blood Products: A Market Briefing In addition to being one of the most important tissues in the body, blood has emerged as a key vector in the transmission of the world's deadliest infectious diseases. With the rising demand for transfusions in a variety of conditions such as anemias, trauma, and high-blood-loss surgeries, supplies have been  |  more... Search inside this report	Jun 1, 2005	$995.00
U.S. Markets in Analytical Chip Technology: Gene, Protein, Tissue, Cell, and Microbiological Microarrays, 2nd Ed. Analytical microchips continue to be among the fastest growing technology segments of the life sciences. The range of applications to which these miniature laboratories may be directed is very broad, covering fields as different as pharmaceutical development, food testing, clinical diagnostics, forensics, and environmental analysis. Moreover, while the number  |  more... Buy by the section | Search inside this report	Jun 1, 2005	$3,500.00
Informatics in Drug Discovery: The Evolving Information Technology Marketplace Within the world of life science research, informatics plays a key role. A few years ago, this market space was occupied primarily by a few niche players, but over the past five years, established companies have expanded their offerings and hundreds of new software companies have surfaced.  |  more... Buy by the section | Search inside this report	May 1, 2005	$3,000.00
Nucleic Acid-Based Therapeutics: World Markets, Developments, and Applications The concept of nucleic acid-based therapeutics is not a new one. For a long time it has been thought that molecules similar to those that make up our genetic structure would make effective therapeutics. It is an idea whose time has come. There are six types of nucleic acid-based  |  more... Buy by the section | Search inside this report	Jan 1, 2005	$3,500.00
Molecular Nanotechnology in Medicine: A Market Briefing Nanotechnology is no longer a bench-top curiosity. It is becoming a real commercial force for a variety of applications. This market briefing discusses the state of play in the race to commercialize products and forecasts likely market scenarios. The briefing forecasts the market in generally promising areas such as cancer  |  more... Search inside this report	Sep 1, 2004	$895.00
Early Stage Drug Discovery 2004: Combi-chem & High Throughput Screening Revisited Ten years ago, high throughput screening (HTS) was being touted as the answer to improving productivity in drug discovery. If screening thousands of compounds a week was good, screening hundreds of thousands would be even better. This led to the boom in Ultra HTS (UHTS), manufacturing-scale systems, and  |  more... Buy by the section | Search inside this report	Jun 1, 2004	$2,995.00
Monoclonal Antibodies in Cancer Therapy: Emerging Products and Markets In 2003, the market for monoclonal antibodies in the treatment of cancer is just short of $2.8 billion and growing at a phenomenal rate. The market is fueled by leading products such as Rituxan and Herceptin; however, other products continue to demand more attention each year. This study  |  more... Buy by the section | Search inside this report	Jun 1, 2004	$3,500.00
Trends in Cell Therapeutics: Promise and Reality Cell and tissue therapies are about to revolutionize the treatment of a number of diseases, including: organ, replacement, cartilage, skin, autoimmune diseases, diabetes, neurodegenerative diseases, cancer and cardiovascular tissue damage. Although cell therapy is not a new phenomenon, what is new is the scope and versatility of research using stem  |  more... Buy by the section | Search inside this report	Mar 1, 2004	$3,500.00
The Emerging Cancer Vaccine Market Immunologic approaches to cancer therapy are not only increasing in reputation and number, but the market for these products is increasingly becoming a reality. Vaccines are in the forefront of this approach to cancer, and the handful of cancer vaccine products currently on the market for bladder, colon, and skin  |  more... Buy by the section | Search inside this report	Feb 1, 2004	$3,500.00
Drug Delivery Technology and Applications: A summary of Kalorama's market research, 2001-2003 Over the past three years, Kalorama Information's analysts have studied drug delivery markets from several angles. In 2001 and 2002, we published a 5-volume series on drug delivery technology, each volume devoted to a route of administration: Volume I: Oral Drug Delivery Volume II: Injectable and Implantable Drug Delivery  |  more... Search inside this report	Nov 7, 2003	$746.00
The Market for Lead Optimization Tools and Services: Applying the new "-omics" to enhance drug discovery The process of creating a new drug is lengthy and complex. From discovery to development to market, there are numerous pitfalls. In this report, Kalorama focuses on one of the trickiest yet also most promising areas: the interface between discovery and development known as lead optimization. The pressure is  |  more... Buy by the section | Search inside this report	Nov 1, 2003	$1,875.00
The Worldwide Market for Orthopedic Biomaterials In today's world of Orthopedic Biomaterials, one thing that is expanding rapidly is the amount of new products in the research pipeline: stem cells, bone growth factors, gene therapy, synthetic bone fillers, bioactive implant coatings and biopolymers among others. The overall market is expected to enjoy healthy growth over the  |  more... Buy by the section | Search inside this report	Jul 1, 2003	$2,625.00
Successful Commercialization Strategies for New Healthcare Products and Technologies According to the Pharmaceutical Research and Manufacturers of America (PhRMA) more than 1,000 drugs are in various stages of development. Similarly, breakthroughs in the medical device arena such as coronary stents, implantable defibrillators, and minimally invasive bypass surgery and advances in DNA-based tests and other advanced diagnostics are detecting  |  more... Buy by the section | Search inside this report	Jun 1, 2003	$1,496.00
Genetic Testing: Markets and Users in Medical, Forensic, Paternity, and Food Safety Applications Genetic testing is already in widespread use and will continue to grow in many application areas in the next five years. The number of companies offering genetic testing services and/or commercial genetic testing products continues to grow around the world. There are at least 50 companies offering genetic  |  more... Buy by the section | Search inside this report	May 1, 2003	$2,625.00
Outsourcing in Drug Discovery The number and scope of drug discovery outsourcing agreements has grown rapidly over the past five years, and the pace will accelerate over the next five years. Outsourcing is now an essential part of drug discovery. Major pharmas and biotechs are aggressively pursuing a range of outsourcing agreements.  |  more... Buy by the section | Search inside this report	May 1, 2003	$2,062.00
U.S. Markets in Analytical Chip Technology: Gene, Protein, Tissue, Cell, and Microbiological Microarrays The world of analytical microchips is the fastest growing technology segment in the life sciences today. The range of applications to which these miniature laboratories may be directed is very broad--covering fields as different as pharmaceutical development, food testing, clinical diagnostics, forensics, and environmental analysis. Moreover, while the  |  more... Buy by the section | Search inside this report	Mar 1, 2003	$2,625.00
Enabling Technologies in Drug Discovery Research Package Kalorama's Proteomics 50: Competing Technologies & Alliances in an Emerging Industry November 2001 Abstract : With the Human Genome Project in its culminating phase, scientists are turning to the task of converting the soon to be completed DNA sequence into information that will improve human medicine and health care. One  |  more... Search inside this report	Sep 1, 2002	$2,999.00
Title	Published	Price

<< back 1 2 3 4 next >>